Russell Investments Group
PRME icon

Russell Investments Group’s Prime Medicine PRME Stock Holding History

Russell Investments Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Sell
50,994
-13,279
-21% -$44.1K ﹤0.01% 3201
2026
Q1 		$224K Buy
64,273
+57,446
+841% +$219K ﹤0.01% 2815
2025
Q4 		$23.7K Hold
6,827
– – ﹤0.01% 3568
2025
Q3 		$37.8K Buy
6,827
+6,345
+1,316% +$25.8K ﹤0.01% 3381
2025
Q2 		$1.19K Buy
482
+430
+827% +$663 ﹤0.01% 3651
2025
Q1 		$103 Sell
52
-336
-87% -$857 ﹤0.01% 3752
2024
Q4 		$1.13K Buy
388
+336
+646% +$1.18K ﹤0.01% 3514
2024
Q3 		$201 Sell
52
-29
-36% -$134 ﹤0.01% 3631
2024
Q2 		$416 Buy
+81
New +$491 ﹤0.01% 3513

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's PRME Position: Q2 2026 in Review

Russell Investments Group reduced its Prime Medicine (PRME) stake by 21% in Q2 2026, selling an estimated $44.1K and leaving 50,994 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Russell Investments Group first reported a position in PRME in Q2 2024 and has held it in 9 quarters since. The position peaked at $224K in Q1 2026. 69 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Russell Investments Group held 50,994 shares of Prime Medicine worth $188K as of Q2 2026.
  • Russell Investments Group sold 13,279 Prime Medicine shares in Q2 2026, an estimated $44.1K.
  • Prime Medicine made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3201 holding.
  • Russell Investments Group first reported a position in Prime Medicine in Q2 2024 and has held it in 9 quarters since.
  • Russell Investments Group's Prime Medicine position peaked at $224K in Q1 2026.
  • 69 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.